Rezziki Abdellah, El Malki Hicham, Boukabous Sara, Banana Youssef, Meftah Hicham, Haddiya Intissar, Bentata Yassamine, Moutaouekkil El Mehdi, Benzirar Adnane, El Mahi Omar
Department of Vascular Surgery, Mohammed VI University Hospital of Oujda, Mohammed First University of Oujda, Morocco.
Laboratory of Epidemiology, Clinical Research and Public Health, Faculty of Medicine and Pharmacy, Mohammed the First University of Oujda, Morocco.
Ann Med Surg (Lond). 2022 Mar 3;76:103438. doi: 10.1016/j.amsu.2022.103438. eCollection 2022 Apr.
Central venous Occlusion (CVO) is a serious complication that occurs mainly in patients with long term central venous catheters for dialysis. It remains a challenge in vascular surgery.
We report a case of a patient with end-stage kidney disease (ESKD), who was admitted for chronic occlusion of the superior and inferior vena cava and underwent a right subclavian artery to right atrium (RA) bypass using polytetrafuloroetylene (PTFE) graft.
Central venous catheters remains the main cause of CVO in ESKD. Although the endovascular therapy is the main approach in the treatment of CVO, the surgical bypass to the RA is often the last resort to preserve vascular access in hemodialysis patients. The autologous vein and bovine arterial bypass remains better than PTFE grafts in terms of long term patency.
fistulas as a first approach for dialysis access must be privileged at the expense of central catheters. However bypass to RA by mini thoracotomy incision remains as an excellent option for dialysis access in ESKD with CVO.
中心静脉闭塞(CVO)是一种严重并发症,主要发生于长期使用中心静脉导管进行透析的患者。它仍是血管外科领域的一项挑战。
我们报告一例终末期肾病(ESKD)患者,因上、下腔静脉慢性闭塞入院,接受了使用聚四氟乙烯(PTFE)移植物进行的右锁骨下动脉至右心房(RA)旁路移植术。
中心静脉导管仍是ESKD患者发生CVO的主要原因。虽然血管内治疗是CVO的主要治疗方法,但对RA进行外科旁路移植术往往是维持血液透析患者血管通路的最后手段。就长期通畅性而言,自体静脉和牛动脉旁路移植术优于PTFE移植物。
作为透析通路的首选方法,应优先选择造瘘,减少中心静脉导管的使用。然而,对于伴有CVO的ESKD患者,经小切口开胸进行RA旁路移植术仍是透析通路的一个极佳选择。